Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 5 | BMC Family Practice

Fig. 5

From: Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey

Fig. 5

Percent reporting that patients/clients use cannabis as an adjunctive or drug substitution therapy. Respondents were asked, “If you have ever recommended cannabis as a complementary therapy to [substitute for] a prescription drug, what class/category of drug(s) did you intend to complement [substitute] with cannabis (Check all that apply)?” Bars reflect the % of respondents who selected each class/category. The percentage is labeled at the end of each bar. The gray bar indicates respondents reporting using cannabis as a substitute (n = 64). The black bar indicates respondents reporting using cannabis as an adjunct (n = 74)

Back to article page